Combined elevation of microRNA-196a and microRNA-196b in sera predicts unfavorable prognosis in patients with osteosarcomas

International Journal of Molecular Sciences

Volumn 15, Issue 4, 2014, Pages 6544-6555

  Zhang, Chun ^a   Yao, Cong ^a   Li, Hao Peng ^a   Wang, Guo Yu ^a   He, Xi Jng ^a  

^a THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Clinicopathological features; Disease free survival; MicroRNA 196a; MicroRNA 196b; Osteosarcoma; Overall survival; Serum

Indexed keywords

MICRORNA; MICRORNA 196A; MICRORNA 196B; MOLECULAR MARKER; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MIRN196 MICRORNA, HUMAN;

ADULT; ARTICLE; BLOOD LEVEL; CANCER PROGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MRNA EXPRESSION ASSAY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; OVERALL SURVIVAL; PATHOGENESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION; BLOOD; BONE NEOPLASMS; GENETICS; KAPLAN MEIER METHOD; PROGNOSIS; RECURRENT DISEASE; RISK;

ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICRORNAS; ODDS RATIO; OSTEOSARCOMA; PROGNOSIS; RECURRENCE; UP-REGULATION;

EID: 84899153208     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15046544     Document Type: Article

References (33)

1. Fletcher, C. D. M. Unni, K. K. Mertens, F. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone; IARC Press: Lyon, France, 2002.
2. Kager, L.; Zoubek, A.; Pötschger, U.; Kastner, U.; Flege, S.; Kempf-Bielack, B.; Branscheid, D.; Kotz, R.; Salzer-Kuntschik, M.; Winkelmann, W. et al. Primary metastatic osteosarcoma: Presentation and outcome of patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J. Clin. Oncol. 2003, 21, 2011-2018.
3. Longhi, A.; Fabbri, N.; Donati, D.; Capanna, R.; Briccoli, A.; Biagini, R.; Bernini, G.; Ferrari, S.; Versari, M.; Bacci, G. Neoadjuvant chemotherapy for patients with synchronous multifocal osteosarcoma: Results in eleven cases. J. Chemother. 2001, 13, 324-330.
4. Bacci, G.; Briccoli, A.; Rocca, M.; Ferrari, S.; Donati, D.; Longhi, A.; Bertoni, F.; Bacchini, P.; Giacomini, S.; Forni, C. et al. Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: Recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide. Ann. Oncol. 2003, 14, 1126-1134.
5. Bentwich, I.; Avniel, A.; Karov, Y.; Aharonov, R.; Gilad, S.; Barad, O. Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet. 2005, 37, 766-770.
6. Sassen, S.; Miska, E.A.; Caldas, C. MicroRNA: Implications for cancer. Virchows Arch. 2008, 452, 1-10.
7. Maire, G.; Martin, J.W.; Yoshimoto, M.; Chilton-MacNeill, S.; Zielenska, M. Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma. Cancer Genet. 2011, 204, 138-146.
8. Bouyssou, J. M.; Manier, S. Huynh, D. Issa, S. Roccaro, A. M. Ghobrial, I. M. Regulation of microRNAs in Cancer Metastasis. Biochim. Biophys. Acta 2014, in press.
9. Mollaie, H. R. Monavari, S. H. Arabzadeh, S. A. Shamsi-Shahrabadi, M. Fazlalipour, M. Afshar, R.M. RNAi and miRNA in viral infections and cancers. Asian Pac. J. Cancer Prev. 2013, 14, 7045-7056.
10. Nugent, M. MicroRNA function and dysregulation in bone tumors: The evidence to date. Cancer Manag. Res. 2014, 6, 15-25.
11. Gomez, G.G.; Wykosky, J.; Zanca, C.; Furnari, F.B.; Cavenee, W.K. Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks. Cancer Biol. Med. 2013, 10, 192-205.
12. Suzuki, H.; Maruyama, R.; Yamamoto, E.; Kai, M. Epigenetic alteration and microRNA dysregulation in cancer. Front. Genet. 2013, doi:10.3389/fgene.2013.00258.
13. Yu, H.; Lindsay, J.; Feng, Z.P.; Frankenberg, S.; Hu, Y.; Carone, D.; Shaw, G.; Pask, A.J.; O'Neill, R.; Papenfuss, A. T. et al. Evolution of coding and non-coding genes in HOX clusters of a marsupial. BMC Genomics 2012, doi:10.1186/1471-2164-13-251.
14. Karsy, M.; Arslan, E.; Moy, F. Current progress on understanding microRNAs in glioblastoma multiforme. Genes Cancer 2012, 3, 3-15.
15. Liu, C.J; Tsai, M.M.; Tu, H.F.; Lui, M.T.; Cheng, H.W.; Lin, S.C. miR-196a overexpression and miR-196a2 gene polymorphism are prognostic predictors of oral carcinomas. Ann. Surg. Oncol. 2013, 20, S406-S414.
16. Namlos, H.M.; Meza-Zepeda, L.A.; Baroy, T.; Ostensen, I.H.; Kresse, S.H.; Kuijjer, M.L.; Serra, M.; Bürger, H.; Cleton-Jansen, A.M.; Myklebost, O. Modulation of the osteosarcoma expression phenotype by microRNAs. PLoS One 2012, 7, e48086.
17. Hauptman, N.; Glavac, D. MicroRNAs and long non-coding RNAs: Prospects in diagnostics and therapy of cancer. Radiol. Oncol. 2013, 47, 311-318.
18. McGinnis, W.; Krumlauf, R. Homeobox genes and axial patterning. Cell 1992, 68, 283-302.
19. Tanzer, A.; Amemiya, C.T.; Kim, C.B. Evolution of microRNAs located within HOX gene clusters. J. Exp. Zool. B Mol. Dev. Evol. 2005, 304, 75-85.
20. Guan, Y.; Mizoguchi, M.; Yoshimoto, K.; Hata, N.; Shono, T.; Suzuki, S.O.; Araki, Y.; Kuga, D.; Nakamizo, A.; Amano, T. et al. miRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance. Clin. Cancer Res. 2010, 16, 4289-4297.
21. Schultz, N.A.; Werner, J.; Willenbrock, H.; Roslind, A.; Giese, N.; Horn, T.; Wøjdemann, M.; Johansen, J.S. MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma. Mod. Pathol. 2012, 25, 1609-1622.
22. Dou, T.; Wu, Q.; Chen, X.; Ribas, J.; Ni, X.; Tang, C.; Huang, F.; Zhou, L.; Lu, D. A polymorphism of microRNA196a genome region was associated with decreased risk of glioma in Chinese population. J. Cancer Res. Clin. Oncol. 2010, 136, 1853-1859.
23. Peng, S.; Kuang, Z.; Sheng, C.; Zhang, Y.; Xu, H.; Cheng, Q. Association of microRNA-196a-2 gene polymorphism with gastric cancer risk in a Chinese population. Dig. Dis. Sci. 2010, 55, 2288-2293.
24. Hoffman, A.E.; Zheng, T.; Yi, C.; Leaderer, D.; Weidhaas, J.; Slack, F.; Zhang, Y.; Paranjape, T.; Zhu, Y. microRNA miR-196a-2 and breast cancer: A genetic and epigenetic association study and functional analysis. Cancer Res. 2009, 69, 5970-5977.
25. Mueller, D.W.; Bosserhoff, A.K. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression. Int. J. Cancer 2011, 129, 1064-1074.
26. Bhatia, S.; Kaul, D.; Varma, N. Potential tumor suppressive function of miR-196b in B-cell lineage acute lymphoblastic leukemia. Mol. Cell. Biochem. 2010, 340, 97-106.
27. Tsai, K.W.; Hu, L.Y.; Wu, C.W.; Li, S.C.; Lai, C.H.; Kao, H.W.; Fang, W.L.; Lin, W.C. Epigenetic regulation of miR-196b expression in gastric cancer. Genes Chromosomes Cancer 2010, 49, 969-980.
28. Ma, R.; Yan, W.; Zhang, G.; Lv, H.; Liu, Z.; Fang, F.; Zhang, W.; Zhang, J.; Tao, T.; You, Y. et al. Upregulation of miR-196b confers a poor prognosis in glioblastoma patients via inducing a proliferative phenotype. PLoS One 2012, 7, e38096.
29. Li, Y.; Zhang, M.; Chen, H.; Dong, Z.; Ganapathy, V.; Thangaraju, M.; Huang, S. Ratio of miR-196s to HOXC8 messenger RNA correlates with breast cancer cell migration and metastasis. Cancer Res. 2010, 70, 7894-7904.
30. Hamamoto, J.; Soejima, K.; Yoda, S.; Naoki, K.; Nakayama, S.; Satomi, R.; Terai, H.; Ikemura, S.; Sato, T.; Yasuda, H. et al. Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma. Mol. Med. Rep. 2013, 8, 456-462.
31. How, C.; Hui, A.B.; Alajez, N.M.; Shi, W.; Boutros, P.C.; Clarke, B.A.; Yan, R.; Pintilie, M.; Fyles, A.; Hedley, D. W. et al. MicroRNA-196b regulates the homeobox B7-vascular endothelial growth factor axis in cervical cancer. PLoS One 2013, 8, e67846.
32. Bacci, G.; Bertoni, F.; Longhi, A.; Ferrari, S.; Forni, C.; Biagini, R.; Bacchini, P.; Donati, D.; Manfrini, M.; Bernini, G. et al. Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor. Cancer 2003, 97, 3068-3075.
33. Kroh, E.M.; Parkin, R.K.; Mitchell, P.S.; Tewari, M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 2010, 50, 298-301.